DOLORisk: Research on Risk Factors and Determinants for Neuropathic Pain

CompletedOBSERVATIONAL
Enrollment

1,550

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

June 30, 2019

Study Completion Date

June 30, 2019

Conditions
Neuropathic Pain
Interventions
DIAGNOSTIC_TEST

Quantitative sensory testing (QST)

Demographic data, pain characteristics, health status, emotional well-being, personality and lifestyle are assessed by questionnaires. Additionally, all patients underwent a clinical neurological examination and quantitative sensory testing (QST) according to the German Research Network on Neuropathic Pain (DFNS).

Trial Locations (1)

24105

University of Kiel, Kiel

All Listed Sponsors
collaborator

Horizon 2020 - European Commission

OTHER

collaborator

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV

collaborator

University of Oxford

OTHER

collaborator

Imperial College London

OTHER

collaborator

Technion, Israel Institute of Technology

OTHER

collaborator

University of Aarhus

OTHER

collaborator

Aarhus University Hospital

OTHER

lead

University of Kiel

OTHER

NCT04888455 - DOLORisk: Research on Risk Factors and Determinants for Neuropathic Pain | Biotech Hunter | Biotech Hunter